Christina Hochul is a Senior Director, Head of Strategic Alliance Development at Alexion, AstraZeneca Rare Disease. In this capacity, Christina leads Alexion’s engagement with external stakeholders to develop support for Alexion’s policy initiatives. Prior to joining Alexion, Christina was a Director of Federal Policy at Biogen. Christina also launched Biogen’s Strategic Alliance Department. Christina holds a juris doctor from University of Dayton School of Law and a Master of Laws in Intellectual Property from George Washington University Law School. She received a Bachelor of Science in Cell and Molecular Biology from Tulane University. Christina serves as the Chair of BIO’s Alliance Development Committee, on Patient Access Initiative Steering Committee of the American Kidney Fund and on the Business Council of FasterCures at the Milken Institute.